Alzamend Neuro Inc. (ALZN)
1.15
0.02 (1.77%)
At close: Jan 15, 2025, 1:43 PM
Balance Sheet (Annual)
Get detailed breakdowns of the balance-sheet with total debts, total investments, and much more.
| Year | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 |
| Cash & Equivalents | 376.05K | 5.14M | 14.06M | 1.93M | 90.28K | 42.61K | 545.00K | 4.98K | 1.14K |
| Short-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Long-Term Assets | n/a | -0.00 | 0.00 | 352.50K | n/a | n/a | n/a | 75.00K | 25.00K |
| Receivables | n/a | n/a | n/a | 16.21K | 194.28K | 285.35K | n/a | n/a | n/a |
| Inventory | n/a | n/a | n/a | -16.21K | n/a | n/a | n/a | n/a | n/a |
| Other Current Assets | 79.19K | 694.92K | 349.72K | 614.61K | 1.53M | 1.17M | 1.87M | 52.32K | 4.47K |
| Total Current Assets | 455.24K | 5.84M | 14.41M | 2.91M | 1.81M | 1.50M | 2.42M | 57.29K | 5.61K |
| Property-Plant & Equipment | 176.35K | 79.84K | 102.91K | n/a | n/a | n/a | n/a | n/a | n/a |
| Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Total Long-Term Assets | 176.35K | 79.84K | 102.91K | 352.50K | n/a | n/a | n/a | 75.00K | 25.00K |
| Total Assets | 631.59K | 5.92M | 14.52M | 2.91M | 1.81M | 1.50M | 2.42M | 132.29K | 30.61K |
| Account Payables | 2.93M | 2.87M | 1.16M | 503.59K | 929.64K | 1.10M | 90.09K | 125.97K | 2.60K |
| Deferred Revenue | n/a | n/a | n/a | n/a | -62.67 | -79.33 | n/a | -0.00 | n/a |
| Short-Term Debt | 300.71K | n/a | n/a | 335.30K | 62.67 | 79.33 | n/a | 591.26K | 3.12K |
| Other Current Liabilities | n/a | n/a | 2.08K | 60.75K | 62.60K | 79.25K | 6.64K | n/a | 25.00K |
| Total Current Liabilities | 3.23M | 2.87M | 1.16M | 899.64K | 992.31K | 1.18M | 96.72K | 717.22K | 30.72K |
| Long-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Long-Term Liabilities | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Total Long-Term Liabilities | n/a | n/a | 1.16M | n/a | n/a | 1.10M | n/a | n/a | n/a |
| Total Liabilities | 3.23M | 2.87M | 1.16M | 899.64K | 992.31K | 1.18M | 96.72K | 717.22K | 30.72K |
| Total Debt | 300.71K | n/a | n/a | 335.30K | 62.67 | 79.33 | n/a | 591.26K | 3.12K |
| Common Stock | 69.00 | 9.69K | 9.55K | 6.74K | 6.48K | 6.19K | 4.95K | 3.29K | 4.64K |
| Retained Earnings | -54.02M | -44.07M | -29.19M | -16.83M | -11.79M | -7.38M | -2.51M | -1.58M | -11.58K |
| Comprehensive Income | n/a | -14.88M | -14.88M | -14.88M | -14.98M | -15.00M | -4.95K | n/a | -3.00K |
| Shareholders Equity | -2.59M | 3.05M | 13.35M | 2.01M | 821.71K | 316.92K | 2.32M | -584.93K | -106 |
| Total Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |